I keep seeing people blame their mast cells as if the mast cells simply decided to become overactive.
I do not think that is where the story always begins.
You can block histamine and feel better. You can stabilize mast cells and reduce reactions. But if the gut lining continues sending the same danger signals, the immune system may remain primed—and the symptoms return as soon as that protection is reduced.
That is the pattern I keep seeing in complex cases involving IBS, SIBO, histamine intolerance, MCAS, POTS, food reactions, and “leaky gut.”
Within my Host Capacity Model, these may not be separate problems. They may reflect a gut lining that has lost the metabolic capacity to maintain a stable microbial and immune environment.
One metabolite I increasingly investigate is succinate.
Succinate is normally a temporary intermediate in mitochondrial energy production. It should be converted to fumarate by succinate dehydrogenase (SDH), also known as mitochondrial Complex II.
Gut organisms such as Bacteroides, Prevotella, and Veillonella also produce succinate while fermenting carbohydrates and fiber. Normally, anaerobes such as Phascolarctobacterium and Dialister consume it and convert it toward propionate.
Antibiotics, infection, inflammation, restrictive diets, altered transit, and loss of anaerobic diversity may reduce these succinate consumers.
More fermentation + less succinate clearance = succinate accumulation
This may help explain why some highly reactive people worsen with fiber, prebiotics, or probiotics. The intervention may not be inherently harmful; the ecosystem may no longer have the capacity to process the additional metabolic load.
Healthy colonocytes use butyrate as a major fuel. By oxidizing butyrate, they consume oxygen and maintain epithelial hypoxia—the low-oxygen environment that supports beneficial anaerobes.
When butyrate oxidation fails, oxygen becomes available near the intestinal lining. Inflammation also increases nitrate. This gives organisms such as E. coli, Klebsiella, Citrobacter, Enterobacter, Proteus, and Morganella a respiratory advantage.
Epithelial injury → impaired butyrate oxidation → oxygen and nitrate availability → pathobiont expansion → further inflammation
This is why recurrent dysbiosis may not be only an infection to eradicate. It can be the predictable result of an injured gut environment repeatedly selecting the same organisms.
The same environment may keep mast cells primed.
In the cases I review, I often see epithelial injury alongside elevated LPS-related burden, reduced secretory IgA, inflammatory pathobionts, and impaired barrier function.
LPS can activate TLR4 and NF-κB, increasing inflammatory cytokines. Reduced secretory IgA may weaken immune exclusion, allowing microbial antigens to interact more closely with the intestinal lining and local immune cells.
Barrier injury → microbial exposure → inflammatory signaling → mast-cell priming
Succinate may add another layer.
Outside the cell, succinate activates SUCNR1, also called GPR91. This receptor is expressed by intestinal tuft cells—specialized sentinels that detect parasites and microbial metabolites.
When tuft cells sense succinate, they can release IL-25, activating ILC2 immune cells. ILC2s then produce IL-13 and IL-4, influencing mucus production, epithelial remodeling, parasite defense, and type-2 immune activity.
Succinate → SUCNR1 → IL-25 → ILC2 activation → IL-13/IL-4 signaling
This is a normal protective circuit. But when succinate repeatedly accumulates in an injured gut, the same danger-detection pathway may continue being reactivated.
Mast cells may also express SUCNR1 in certain tissue environments. Succinate could therefore influence them indirectly through tuft-cell/ILC2 signaling and, in some settings, directly through mast-cell SUCNR1.
Activated mast cells release histamine, tryptase, prostaglandins, leukotrienes, and cytokines. These mediators affect the intestine, blood vessels, sensory nerves, motility, and autonomic signaling.
That is how a gut-derived signal may become a whole-body event: flushing, food reactions, itching, brain fog, light sensitivity, palpitations, dizziness, or a sudden internal alarm after eating.
The POTS connection may follow the same network. Mast-cell mediators can promote vasodilation and vascular permeability. After a meal, increased blood pooling may reduce effective circulating volume, forcing the autonomic nervous system to compensate by raising sympathetic activity and heart rate.
Another part of my research examines the succinate-to-α-ketoglutarate ratio.
When intracellular succinate rises relative to α-ketoglutarate, it may inhibit TET DNA demethylases and JMJD histone demethylases—enzymes involved in gene accessibility, epithelial repair, immune adaptation, and metabolic flexibility.
This may create a biological memory of the original injury. The infection, antibiotic exposure, viral illness, mold exposure, or inflammatory event may be gone, while the gut lining remains stress-adapted and the immune system remains easier to trigger.
Succinate is not acting alone. LPS, reduced secretory IgA, barrier injury, inflammatory cytokines, altered microbial ecology, and mitochondrial dysfunction may converge to keep the gut lining—and the mast-cell system—in a reactive state.
Antihistamines and mast-cell stabilizers can still be useful, and prescribed medication should not be stopped without medical guidance. But suppressing the reaction is not the same as identifying the signal repeatedly provoking it.
This is the focus of my Host Capacity Model: understanding why the gut continues telling the immune system that danger is present—and what prevents the host environment from returning to stability.
If this sounds familiar, or you know someone who keeps relapsing despite doing “everything right,” please share this post.
I work privately with a limited number of complex cases. To request a consultation, complete the intake form at www.biomelogic.net or email research@biomelogic.net.